Seed, A., Love, M. P. and McMurray, J. J.V. (2001) Clinical experience with endothelin receptor antagonists in chronic heart failure. Heart Failure Reviews, 6(4), pp. 317-323. (doi: 10.1023/A:1011408425878) (PMID:11447306)
Full text not currently available from Enlighten.
Abstract
Both ETA selective and dual, ETA=B, receptor antagonists have favourable short- and longer-term haemodynamic actions in patients with acute and chronic heart failure. Their effect on neurohumoral measures is not yet fully determined. Two moderately large, medium-duration studies have examined the effect of dual ETA=B receptor antagonists on clinical status, reaching conflicting conclusions. One large scale, long-term, morbidity mortality evaluation is underway with bosentan.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | McMurray, Professor John |
Authors: | Seed, A., Love, M. P., and McMurray, J. J.V. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | Heart Failure Reviews |
Publisher: | Springer |
ISSN: | 1382-4147 |
ISSN (Online): | 1573-7322 |
University Staff: Request a correction | Enlighten Editors: Update this record